IL6 and stroke disorder: In a rat stroke study on MnTnHex-2-PyP5+, we have demonstrated the inhibition of NF-κB and subsequent downregulation of NF-κB-controlled pro-inflammatory cytokines, TNF-α and IL-6 [22].